Form 4: InfuSystem CFO Barry Steele Receives Equity Grant

InfuSystem Holdings, Inc. Executive VP and CFO Barry G. Steele was granted stock options and restricted stock units on May 12, 2026.

Summary

• Executive VP and CFO Barry G. Steele received a grant of 35,668 stock options with an exercise price of $8.37.
• The CFO also received 17,121 restricted stock units (RSUs).
• The stock options vest in four equal annual installments starting May 12, 2027.
• The restricted stock units vest in three equal annual installments starting May 12, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected in the normal course of business.

Positives

• Equity-based compensation aligns the interests of the CFO with long-term shareholder value creation.

Negatives

• The issuance of new equity awards results in potential future dilution for existing shareholders.

Risks

• Future dilution of common stock upon the exercise of options and vesting of RSUs.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive compensation.

Industry Context

StockSavvy.ai notes that equity grants to executive leadership are standard corporate governance practices intended to incentivize long-term performance and retention within the healthcare services sector.

Comparison to Industry Standards

• The use of multi-year vesting schedules for executive equity is consistent with standard compensation practices for publicly traded companies in the U.S. healthcare sector.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity instruments.

Next Steps

• Vesting of restricted stock units beginning May 12, 2027.
• Vesting of stock options beginning May 12, 2027.

Key Dates

Keywords

InfuSystem, INFU, Form 4, Insider Transaction, Equity Compensation, CFO